• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶消化后纤连蛋白上切割位点的定位

Localization of the cleavage sites on fibronectin following digestion by urokinase.

作者信息

Gold L I, Rostagno A, Frangione B, Passalaris T

机构信息

Department of Pathology, New York University Medical Center, New York 10016.

出版信息

J Cell Biochem. 1992 Dec;50(4):441-52. doi: 10.1002/jcb.240500412.

DOI:10.1002/jcb.240500412
PMID:1469074
Abstract

Urokinase (u-PA) proteolytically cleaves both human plasma (pFn) and cellular (cFn) dimeric fibronectin (M(r) 440,000) into four major polypeptides of approximately M(r) 210,000, 200,000, 25,000, and 6,000. Amino acid sequence analysis of the polypeptide fragments indicated that the enzymatic cleavage of Fn occurs at two sites: 1) between an arginine/alanine peptide bond located C-terminal to residue 259; this cleavage liberates the N-terminal M(r) 25,000 fragment and the M(r) 210,000 and M(r) 200,000 polypeptides derived from the A and B chains of Fn, respectively; and 2) between an arginine/threonine peptide bond located C-terminal to residue 2,299, thereby yielding an M(r) 6,000 dimeric fragment containing the C-terminal interchain disulfide bonds. Predigestion of Fn with u-PA increased the molecule's vulnerability to further attack by the enzymes plasmin and cathepsin D. These data provide further biochemical evidence for the proteolytic cleavage of fibronectin by plasminogen activators and substantiate that u-PA digestion of Fn may be an initial event in the local degradation of the extracellular matrix by malignant cells, possessing elevated levels of these enzymes.

摘要

尿激酶(u-PA)可将人血浆(pFn)和细胞(cFn)中的二聚体纤连蛋白(分子量440,000)蛋白水解切割成四种主要多肽,分子量分别约为210,000、200,000、25,000和6,000。对这些多肽片段的氨基酸序列分析表明,Fn的酶切发生在两个位点:1)位于第259位残基C端的精氨酸/丙氨酸肽键之间;这种切割释放出N端分子量25,000的片段以及分别来自Fn A链和B链的分子量210,000和200,000的多肽;2)位于第2299位残基C端的精氨酸/苏氨酸肽键之间,从而产生一个包含C端链间二硫键的分子量6,000的二聚体片段。用u-PA对Fn进行预消化会增加该分子对纤溶酶和组织蛋白酶D进一步攻击的敏感性。这些数据为纤溶酶原激活剂对纤连蛋白的蛋白水解切割提供了进一步的生化证据,并证实u-PA对Fn的消化可能是恶性细胞局部降解细胞外基质的起始事件,恶性细胞中这些酶的水平升高。

相似文献

1
Localization of the cleavage sites on fibronectin following digestion by urokinase.尿激酶消化后纤连蛋白上切割位点的定位
J Cell Biochem. 1992 Dec;50(4):441-52. doi: 10.1002/jcb.240500412.
2
Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).基质溶解素-1(MMP-3)对尿激酶型纤溶酶原激活剂的蛋白水解切割
Biochemistry. 1998 May 19;37(20):7231-6. doi: 10.1021/bi9728708.
3
Human plasma fibronectin as a substrate for human urokinase.人血浆纤连蛋白作为人尿激酶的底物
Biochem J. 1989 Sep 1;262(2):529-34. doi: 10.1042/bj2620529.
4
Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase.通过尿激酶的分离结构域对抗尿激酶单克隆抗体5B4进行表位作图。
Thromb Haemost. 1989 Nov 24;62(3):934-9.
5
Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains.癌细胞释放出一种共价复合物,该复合物包含来自尿纤溶酶原激活物、神经细胞黏附分子以及触珠蛋白α链和β链的二硫键连接结构域。
Arch Biochem Biophys. 1997 Sep 15;345(2):289-98. doi: 10.1006/abbi.1997.0284.
6
Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin.蛋白水解作用调节血浆纤连蛋白中IIICS-1黏附序列的暴露。
Biochemistry. 1996 Aug 20;35(33):10913-21. doi: 10.1021/bi960717s.
7
Induction of fibronectin mRNA by urokinase- and tissue-type plasminogen activator in human skin fibroblasts: differential role of u-PA and t-PA at the fibronectin protein level.
Biol Chem. 2002 Jan;383(1):177-87. doi: 10.1515/BC.2002.018.
8
Identification of an active site residue of the R1 subunit of ribonucleotide reductase from Escherichia coli: characterization of substrate-induced polypeptide cleavage by C225SR1.大肠杆菌核糖核苷酸还原酶R1亚基活性位点残基的鉴定:C225SR1对底物诱导的多肽切割的表征
Biochemistry. 1996 Aug 6;35(31):10058-67. doi: 10.1021/bi952869d.
9
Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.肌动蛋白可通过组织型和尿激酶型纤溶酶原激活剂刺激纤溶酶的生成。
Arch Biochem Biophys. 1993 Nov 15;307(1):138-45. doi: 10.1006/abbi.1993.1572.
10
Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).基质溶解素-1(MMP-3)对细胞相关纤溶酶原激活的调节作用
Thromb Haemost. 1999 Sep;82(3):1127-31.

引用本文的文献

1
Changes in various forms of fibronectin in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass - a prospective, observational study.体外循环下冠状动脉搭桥术患者不同形式纤连蛋白的变化——一项前瞻性观察研究
Sci Rep. 2024 Dec 28;14(1):30790. doi: 10.1038/s41598-024-80765-9.
2
PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like cultures.垂体腺苷酸环化酶激活肽(PACAP)与PAC1受体相互作用,以诱导雪旺氏细胞样培养物中组织纤溶酶原激活物(tPA)的表达和活性。
PLoS One. 2015 Feb 6;10(2):e0117799. doi: 10.1371/journal.pone.0117799. eCollection 2015.
3
A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis.
纤溶酶原激活物系统在实验性变态反应性脑脊髓炎期间中枢神经系统炎症和神经变性中的作用。
Am J Pathol. 2005 Aug;167(2):545-54. doi: 10.1016/S0002-9440(10)62996-3.
4
Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.缺乏组织型纤溶酶原激活物(tPA)、尿激酶型纤溶酶原激活物(uPA)或纤溶酶原基因的小鼠在坐骨神经挤压后功能恢复延迟。
J Neurosci. 2001 Jun 15;21(12):4348-55. doi: 10.1523/JNEUROSCI.21-12-04348.2001.
5
Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model.合成尿激酶抑制剂对小鼠乳腺肿瘤模型局部侵袭和转移的影响。
Breast Cancer Res Treat. 1996;40(3):209-23. doi: 10.1007/BF01806809.
6
The urokinase receptor is required for human monocyte chemotaxis in vitro.体外人类单核细胞趋化性需要尿激酶受体。
J Clin Invest. 1994 Apr;93(4):1380-7. doi: 10.1172/JCI117114.